Literature DB >> 6613996

The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types.

J Zlotogora, M Sagi, T Cohen.   

Abstract

The blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is rare and autosomal dominant. A family is presented and analyzed together with 38 kindreds with BPES reported in the literature. The results demonstrate the existence of two types of the syndrome: type I with infertility in affected females, and type II which is transmitted by females and males. The two entities are further differentiated by incomplete penetrance only in type II and by differences in the sex ratios of the affected children. Female infertility in type I is a predominant symptom, and the distinction between the two types is of importance for genetic counseling.

Entities:  

Mesh:

Year:  1983        PMID: 6613996      PMCID: PMC1685801     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  [Problems in ocular genetics. IV. Ptosis with congenital hereditary blepharophimosis].

Authors:  L GEDDA; S BERARD-MAGISTRETTI
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1959-01

2.  Hereditary blepharophimosis, ptosis, and epicanthus inversus.

Authors:  N OWENS; R C HADLEY; H W KLOEPFER
Journal:  J Int Coll Surg       Date:  1960-05

3.  [Macular heterotopia with blepharophimosis in two generations].

Authors: 
Journal:  Bull Soc Belge Ophtalmol       Date:  1957

4.  [Not Available].

Authors:  J EDMUND
Journal:  Acta Genet Stat Med       Date:  1957

5.  [A familial case of eyelip ptosis with blepharophimosis and epicanthus inversus].

Authors:  G Fontaine; P François; P Razemon; J P Farriaux; R Walbaum
Journal:  J Genet Hum       Date:  1974-09

6.  [Genetic study of familial blepharophimosis (autosome dominant disease)].

Authors:  C Stoll; J M Levy; P Bigel; J J Francfort
Journal:  J Genet Hum       Date:  1974-12

7.  [Familial blepharophimosis (study of 3 genealogies)].

Authors:  L Aubert; H Arroyo; P Detolle; M Mercier; R Riu; P Darleguy; R Gacon
Journal:  Mars Med       Date:  1967

8.  Blepharoptosis, blepharophimosis, epicanthus inversus, and telecanthus--a syndrome with no name.

Authors:  R Kohn; P E Romano
Journal:  Am J Ophthalmol       Date:  1971-09       Impact factor: 5.258

9.  [Existence of female sterility during a familial ptosis-blepharonphimosis-epicanthus syndrome].

Authors:  A M Larmande; M P Delplace; C Moraine; S Devlamynck
Journal:  Bull Mem Soc Fr Ophtalmol       Date:  1978

10.  Blepharophimosis, ptosis, epicanthus inversus, and primary amenorrhea. A dominant trait.

Authors:  P L Townes; E K Muechler
Journal:  Arch Ophthalmol       Date:  1979-09
View more
  53 in total

Review 1.  A novel case of unilateral blepharophimosis syndrome and mental retardation associated with de novo trisomy for chromosome 3q.

Authors:  T Cai; D A Tagle; X Xia; P Yu; X X He; L Y Li; J H Xia
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome.

Authors:  D Beysen; J Raes; B P Leroy; A Lucassen; J R W Yates; J Clayton-Smith; H Ilyina; S Sklower Brooks; S Christin-Maitre; M Fellous; J P Fryns; J R Kim; P Lapunzina; E Lemyre; F Meire; L M Messiaen; C Oley; M Splitt; J Thomson; Y Van de Peer; R A Veitia; A De Paepe; E De Baere
Journal:  Am J Hum Genet       Date:  2005-06-16       Impact factor: 11.025

3.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

4.  FOXL2 mutations in Indian families with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Jeyabalan Nallathambi; Guruswamy Neethirajan; Kim Usha; Jethani Jitendra; Elfride De Baere; Periasamy Sundaresan
Journal:  J Genet       Date:  2007-08       Impact factor: 1.166

5.  FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Juan Wang; Jinling Liu; Qingjiong Zhang
Journal:  Mol Vis       Date:  2007-01-26       Impact factor: 2.367

6.  A gene for premature ovarian failure associated with eyelid malformation maps to chromosome 3q22-q23.

Authors:  P Amati; P Gasparini; J Zlotogora; L Zelante; J C Chomel; A Kitzis; J Kaplan; D Bonneau
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

7.  Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.

Authors:  S Nuovo; M Passeri; E Di Benedetto; M Calanchini; I Meldolesi; M C Di Giacomo; D Petruzzi; M R Piemontese; L Zelante; F Sangiuolo; G Novelli; A Fabbri; F Brancati
Journal:  J Endocrinol Invest       Date:  2015-06-23       Impact factor: 4.256

8.  An individual with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and additional features expands the phenotype associated with mutations in KAT6B.

Authors:  Hung-Chun Yu; Elizabeth A Geiger; Livija Medne; Elaine H Zackai; Tamim H Shaikh
Journal:  Am J Med Genet A       Date:  2014-01-23       Impact factor: 2.802

9.  Identification of copy number variants associated with BPES-like phenotypes.

Authors:  Antoinet C J Gijsbers; Barbara D'haene; Yvonne Hilhorst-Hofstee; Marcel Mannens; Beate Albrecht; Joerg Seidel; David R Witt; Melissa K Maisenbacher; Bart Loeys; Ton van Essen; Egbert Bakker; Raoul Hennekam; Martijn H Breuning; Elfride De Baere; Claudia A L Ruivenkamp
Journal:  Hum Genet       Date:  2008-10-25       Impact factor: 4.132

10.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.